Assignee
ATAI Life Sciences AG
DE·4 granted patents·15 pending applications·20 citations·filing 2022–2024
Top patents by PatentIndex Score
19 records- 0196US11643391B2Prodrugs and conjugates of dimethyltryptamineATAI Life Sciences AG·Filed 2022·Granted May 9, 2023·7 cites·8 claims
- 0295US11602521B2N,N-dimethyltryptamine compositions and methodsATAI Life Sciences AG·Filed 2022·Granted Mar 14, 2023·6 cites·27 claims
- 0394US11912680B2Nitric oxide releasing prodrugs of MDA and MDMAATAI Life Sciences AG·Filed 2022·Granted Feb 27, 2024·3 cites·62 claims
- 0494US11827580B2Aminotetraline activators of serotonin receptorsATAI Life Sciences AG·Filed 2022·Granted Nov 28, 2023·4 cites·58 claims
- 0572US2023041584A1Novel prodrugs and conjugates of dimethyltryptamineATAI Life Sciences AG·Filed 2022·Application pending·0 cites
- 0667US2024408054A1Compositions and methods for increasing exposure of r(-)-mdaATAI Life Sciences AG·Filed 2024·Application pending·0 cites
- 0766US2024425470A1Substituted benzofuran propyl amine modulators of monoaminergic transportersATAI Life Sciences AG·Filed 2024·Application pending·0 cites
- 0864US2023097530A1Enantiomeric ratios of 3,4-methylenedioxymethamphetamine and related metabolites and uses thereofATAI Life Sciences AG·Filed 2022·Application pending·0 cites
- 0964US2023129723A1Enantiomeric ratios of 3,4-methylenedioxymethamphetamine and related metabolites and uses thereofATAI Life Sciences AG·Filed 2022·Application pending·0 cites
- 1063US2024116896A1Heteroatom substituted cyclic and alkyl amines as activators of serotonin receptorsATAI Life Sciences AG·Filed 2023·Application pending·0 cites
- 1162US2023136824A1N-n-dimethyltryptamine (dmt) and dmt analog compositions, methods of making, and methods of use thereofATAI Life Sciences AG·Filed 2022·Application pending·0 cites
- 1262US2024082212A1Use of mdma for treatment of stress-related disordersATAI Life Sciences AG·Filed 2023·Application pending·0 cites
- 1361US2023024991A1Prodrugs of acyl carnitinesATAI Life Sciences AG·Filed 2022·Application pending·0 cites
- 1461US2023310374A1Compositions and methods for treating headache or facial painATAI Life Sciences AG·Filed 2023·Application pending·0 cites
- 1557US2023100844A1Ibogaine combination treatmentATAI Life Sciences AG·Filed 2022·Application pending·0 cites
- 1657US2023099972A1Compositions and methods for treating headachesATAI Life Sciences AG·Filed 2022·Application pending·0 cites
- 1757US2023270714A1Salvinorin compositionsATAI Life Sciences AG·Filed 2022·Application pending·0 cites
- 1852US2024069645A1Gesture recognition with healthcare questionnairesATAI Life Sciences AG·Filed 2023·Application pending·0 cites
- 1950US2023109467A1Preparation of optically active enantiomers of piperonyl amines by resolution of the diastereomeric saltsATAI Life Sciences AG·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ATAI Life Sciences AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →